Benjamin Lewis
( out of 18 reviews )

Benjamin Lewis, MD

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Mental Health Institute Crisis Care Center

955 West 3300 South
Salt Lake City , UT 84119
Get Directions

Benjamin Lewis, MD, Associate Professor (Clinical), practices inpatient adult psychiatry at the University of Utah Huntsman Mental Health Institute where his clinical interests involve the diagnosis and treatment of major psychiatric disorders. He has additional interests in medical ethics, the philosophy of psychiatry, and the emerging science and clinical applications of psychedelic medicine.

Specialties

Board Certification

American Board of Psychiatry & Neurology (Psychiatry)

Patient Rating

5.0 /5
( out of 18 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

Benjamin Lewis, MD, Associate Professor (Clinical), practices inpatient adult psychiatry at the University of Utah Huntsman Mental Health Institute where his clinical interests involve the diagnosis and treatment of major psychiatric disorders. He has additional interests in medical ethics, the philosophy of psychiatry, and the emerging science and clinical applications of psychedelic medicine.

Board Certification and Academic Information

Academic Departments Psychiatry -Associate Professor (Clinical)
Academic Divisions Adult Psychiatry
Board Certification
American Board of Psychiatry & Neurology (Psychiatry)

Education history

Chief Resident University of Utah Chief Resident
Chief Resident University of Utah Assistant Chief Resident
Residency Adult Psychiatry - University of Utah Resident
Professional Medical Medicine - University of Iowa College of Medicine M.D.
Undergraduate English [Magna cum Laude] - Harvard University A.B.

Selected Publications

Journal Article

  1. Garland, Eric L Lewis, Benjamin R Thielking, P Odette, Madeleine Pfeffer, H Shen, J (2026). Ketamine-assisted Mindfulness-Oriented Recovery Enhancement for opioid use disorder: a randomized controlled trial. Nature Mental Health.
  2. Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL (2025). Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial. PLoS Med, 22(9), e1004519.
  3. Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking P (2023). HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer. J Pain Symptom Manage, 66(3), 258-269.
  4. Kious BM, Lewis BR, Kim SYH (2023). 'What does epistemic injustice add? A response to Grim and Aftab'. Psychol Med, 53(12), 5879-5881.
  5. Byrne K, Lindsay S, Baker N, Schmutz C, Lewis B (2023). In Naturalistic Psychedelic Use, Group Use is Common and Acceptable. J Psychedelic Stud, https://doi.org/10.1556/2054.2023.00261.
  6. Lewis BR, Hendrick J, Byrne K, Garland E, Thielking P, Beck A (2023). Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial. J Psychedelic Stud, https://doi.org/10.1556/2054.2022.00222.
  7. Kious BM, Lewis BR, Kim SYH (2023). Epistemic injustice and the psychiatrist. Psychol Med, 53(1), 1-5.
  8. Kious BM, Schwartz Z, Lewis BR (2022). Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers. J Psychopharmacol, 37(1), 45-48.
  9. Lewis BR, Byrne K (2021). Update on Psychedelic Therapies for Mental Health. Clinical and Forensic Toxicology News, 1-5.
  10. Case GA, Pippitt KA, Lewis BR (2018). Shame. Perspect Med Educ, 7(Suppl 1), 12-15.
  11. Benjamin R Lewis MD, Matthew J Reid PhD, Andrew Novick MD, Kevin Byrne MD, Mark J Niciu MD, PhD, Gregory A Fonzo PhD, Thomas Meyer PhD, David Feifel MD, PhD, Rifaat El-Mallakh MD, Jair Soares MD, PhD, Trisha Suppes MD, PhD, Frederick S Barrett PhD (). Challenges with Clinical Trial Participants in Studies with Classical Psychedelics: A Position Statement from the National Network of Depression Centers’ Task Group on Psychedelics and Related Compounds. . (Epub ahead of print) Journal of Psychopharmacology.
  12. Lewis BR, Garland E (). Is Ketamine Really a Dissociative? Effects of Ketamine-Assisted Mindfulness-Oriented Recovery Enhancement on Interoceptive Awareness in Patients with Opioid Use Disorder Treated with Buprenorphine. (Epub ahead of print) under review.
  13. Lewis BR, Garland E, Schwartz Z, Xin Y, Byrne K, Kious B (). What’s Good for the Goose? Study Participant Perceptions as to the Relevance of Therapist and Study Team Prior Personal Psychedelic Experience. (Epub ahead of print) under review.

Review

  1. Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett FS (2025). Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds. [Review]. EClinicalMedicine, 89, 103517.
  2. Lewis BR, Byrne K (2023). A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder. [Review]. Focus (Am Psychiatr Publ), 21(3), 247-256.
  3. Lewis BR, Byrne K (2021). Is MDD the right target for early-stage psychedelic-assisted therapy trials? [Review]. J Psychedelic Stud, 5(2), 65-68.

Book Chapter

  1. Lewis BR, Kious BM (2015). The organic-functional distinction. In Cautin R, Lilienfeld (Eds.), Encyclopedia of Clinical Psychology. Wiley-Blackwell.

Conference Proceedings

  1. Lewis B (2011). Taking the Psychiatric Stance: Mental Illness in Dennettian Context. AAPP Bulletin, pending publication in Oxford U Press compilation of essays on philosophical issues in evidence-based psychiatry. Advancement of Philosophy of Psychiatry (AAPP).

Commentary

  1. Lewis BR, Byrne K, Beck A (2023). Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer). Journal of anesthesiology and pain therapy, 4(3), 1-3.
  2. Lewis BR (2021). Some aspects of containment matter. Philos Psychiatr Psychol, 28(3), 223-225.
  3. Lewis BR (12/18/15). "The Drugs Didn't Mix: On the Overvaluation of Misvaluation". Philos Psychiatr Psychol, 22(1), 41-43.
  4. Lewis BR (2015). On the Overvaluation of Misvaluation. Philos Psychiatr Psychol, 22(1).

Editorial

  1. Loughlin M, Bluhm R, Fuller J, Buetow S, Borgerson K, Lewis BR, Kious BM (2015). Diseases, patients and the epistemology of practice: mapping the borders of health, medicine and care. J Eval Clin Pract, 21(3), 357-64.

Letter

  1. Benjamin R Lewis (2026). On Bringing The Flowers: 5 Principles for Group Psilocybin-Assisted Therapy [Letter to the editor]. MAPS Bulletin, XXXVI.
  2. Kious BM, Lewis BR, Kim SYH (2023). What does epistemic injustice add? A response to Grim and Aftab [Letter to the editor]. Psychol Med, 53(12), 5879-5881.
  3. Kious BM, Lewis BR (2018). Classifying psychiatric disorders as communicable diseases. [Letter to the editor]. Lancet Psychiatry, 6(1), 13-14.

Research Lab

News & Podcasts

News